Delivery Order SPE2DB24D2205-SPE2DB25FDYBH

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, with a potential value of $1,741.62, is for the delivery of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract, valued at $1,741.62, to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has a ceiling value of $18,010.28 and an ultimate completion date of June 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of medical products...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The contract is a Firm Fixed Price agreement with a ceiling value of $10,747.52 and an ultimate completion date of September 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, is the prime contractor and will be responsible for...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a ceiling value of $1,659.78 and a completion date of November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml medication, valued at $9,063.52. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,528.49 to Amerisourcebergen Drug Corp for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is providing these essential medical supplies through its corporate office division. This contract is associated with a larger Indefinite Delivery Contract (IDC) valued up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,502.85 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a total potential value of $999,999,999.00 and a period...
The U.S. Defense Logistics Agency (DLA) awarded a $33,066.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML medication. This order is part of a larger single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYBH
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract, valued at $17,221.48, has a completion date of February 10, 2025. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.

Generated 5/9/25, 9:45 AM